Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2026 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2026 Earnings Call Transcript May 12, 2026

Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.33, expectations were $-0.40278.

Operator: Good day, and thank you for standing by. Welcome to the Acumen Pharma First Quarter 2026 Conference Call and Webcast. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Alex...